Tri-Sprintec (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Tri-Sprintec drug offered from Teva Pharmaceuticals USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | norgestimate and ethinyl estradiol |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-12-29 |
| END MARKETING DATE: | 0000-00-00 |
Tri-Sprintec HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tri-Sprintec from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2003-12-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0555-9018_996150d4-3f11-4bfc-8bf2-53fcdd96f5cd |
| PRODUCT NDC: | 0555-9018 |
| APPLICATION NUMBER: | ANDA075808 |